Dr. Katarzyna Zarychta, PhD, MSc Eng With over two decades of experience in the healthcare industry, Dr. Katarzyna Zarychta is a recognized expert at the intersection of cutting-edge technology, innovation, and holistic health. She holds a PhD in Laser Physics from Sorbonne University (Paris), along with Master’s degrees in Physics and Biomedical Engineering. Augmenting her scientific credentials, she has completed executive education programs at Harvard Business School and Harvard Medical School, and holds certified coaching diplomas. Dr. Zarychta has built a distinguished career evaluating transformative medical technologies and digital health solutions, serving as an Expert Advisor and Evaluator for the European Commission and contributing to global initiatives such as the WHO GATE program. Her ability to assess novel innovations is grounded in her deep technical expertise and strategic insight, honed through leadership roles across Europe, Asia-Pacific, and the Middle East. She currently serves on the boards of multiple companies, where she leverages her unique blend of scientific knowledge, business acumen, and global perspective to guide organizations through complex challenges and accelerate the development of patient-centered healthcare solutions. Driven by a passion for impactful innovation, Dr. Zarychta continues to champion advancements that improve well-being and redefine the future of healthcare.
Please log into your account to view faculty contact details.
Mental health is increasingly strained by digital pressures like social media, burnout and isolation, yet technology also offers new paths to care. From AI-driven apps to virtual therapy and support platforms, digital tools are transforming how emotional well-being is managed across all ages. Addressing the global mental health crisis requires not only innovation but also systemic change, funding...
READ MOREAI is transforming global healthcare by improving diagnostics, personalised medicine, telehealth and operational efficiency. While regions like Europe and the US lead in regulation and innovation, the Middle East emerges as a key player with significant investments in smart healthcare. Challenges remain, including algorithmic bias and infrastructure gaps, but AI's potential for enhanced patient...
READ MOREMarket entry business decisions are critical in healthcare, and the impact of mistakes, clinical trial failures and ethical lapses can be profound. Such bad business decisions have led to significant financial losses, damaged reputations, and risks to patient safety, underscoring the imperative of ethical conduct and rigorous validation in healthcare innovation and business strategy.  
READ MORE
